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Chronic Liver Diseases are among the most extensive diseases globally and are related to significant 
morbidity and mortality. Although physical well-being has long been the primary goal of medical care, 
as chronic disease becomes more prevalent in developed countries, there has been a greater focus on 
patients' emotional and social well-being. This study aimed to describe the self-efficacy among chronic 
liver disease patients in North Sumatra, Indonesia. This study uses a cross-sectional design. The study 
assessed 102 chronic liver disease patients from two hospitals using the Chronic Disease Self-Efficacy 
Scales Indonesian version. The participants had moderate self-efficacy (58.8%), followed by high self-
efficacy (38.2%). The majority of the patients in this study had moderate self-efficacy because many 
individuals with chronic liver disease suffer chronic fatigue, abdominal pain and swelling, itchy skin, 
nausea or vomiting, loss of appetite, and other symptoms that affect self-efficacy.  Health professionals 
should strengthen patients' self-efficacy by engaging in positive activities and enhancing their coping 
skills. 
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INTRODUCTION 
Chronic Liver Disease (CLD) has shown 
a serious impact on patients' well-being and 
devotes to the important morbidity associated 
with these conditions.1 Chronic Liver 
Diseases are among the most extensive 
diseases globally and are related to significant 
morbidity and mortality. Hepatitis B virus 
(HBV) and hepatitis C virus (HCV) are the 
major familiar causes of CLD, with HBV 
estimated to affect 360 million people 
worldwide and HCV affecting another 200 
million. Several distinct complications of 
cirrhosis include hepatic encephalopathy, 
ascites, and variceal bleedings.2 And also, 
jaundice, fatigue, dyspnea and can affect daily 
life. These complications seriously affect the 
quality of life for patients with CLD, as these 
patients suffer many effects. 
Self-efficacy attributes an individuals' 
perception about whether they can achieve a 
particular activity. In another way, it is an 
individual's judgment or level of confidence 
about what they can and cannot do pass the 
various tasks and situations. Self-efficacy 
creates a disparity in how people feel, think, 
and act.3 Self-efficacy relates to a general 
sense of confidence in people's abilities to 
accomplish the desired outcome. Self-
enhancing or self-debilitating ways in how 
individuals think optimistically or 
pessimistically, affected by efficacy belief.4 
Researchers found an association between 
self-efficacy and mild physical activity5. 
Patients who can manage their chronic 
diseases are urged to partner with 
professionals to learn the most effective ways 
to maintain a high quality of life at home. 
Self-efficacy refers to confidence 
inability to achieve specific achievement. In 
general, chronic liver diseases are deliberate 
in progression, long in duration, and require 
medical treatment because the long 
recrudescent course of the disease exercises a 
considerable negative effect on patient health 
and lifestyle.6 
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Indonesia is the third country of hepatitis 
B in the Asia Pacific region after China and 
India. Approximately 13 million Indonesians 
have been affected by hepatitis B, and about 
four (4) million are affected by hepatitis C. 
Quality of life may be diminished in patients 
with chronic liver diseases. HRQoL defines 
patients' subjective assessment regarding the 
physical, mental, and social dimensions of 
well-being. And it has also altered to an 
important part in clinical and epidemiological 
studies in gastroenterology and hepatology.7 
Understanding chronic liver disease 
patients' self-efficacy can help increase 
patients' quality of life with this disease. This 
research is also expected to provide additional 
information for nurses and health workers to 
pay more attention to patients with chronic 
liver disease self-efficacy. 
 
MATERIAL AND METHODS 
This is a cross-sectional study using the 
Chronic Disease Self-Efficacy Scales 
Indonesian Version instruments that consist 
of 33 questions. Stanford Patient Education 
Research Center develops the scale to define 
self-efficacy for all kinds of chronic diseases. 
The questionnaire has done forward and 
backward translation.8 Scoring of the 
questionnaires divided into three categories, 
namely low (33-132), medium (133-231), and 
high (232-330) self-efficacy. It used a 
quantitative approach to describe the 
demography and self-efficacy of the patients 
in two hospitals. Descriptive statistics were 
calculated for the study population. This study 
was conducted on Sumatra island, namely 
North Sumatra, Indonesia. The self-efficacy 
instrument using  
This study used purposive sampling, 
recruited all the chronic liver disease patients 
based on the inclusion and exclusion criteria 
from two hospitals as respondents in that 
period. There are  102 participants (63 patients 
from Adam Malik General Hospital and 39 
patients from Sidikalang General Hospital). 
The patients who visited the outpatients and 
inpatients department were invited to 
participate in the study. The researcher waited 
for the patients at the outpatient department 
clinic and visited the patients who stay in the 
inpatient department. 
This study's inclusion criteria were 
inpatients or outpatients with chronic liver 
disease over a period greater than six 
months,9 and patients must be able to answer 
the questionnaire questions (compos mentis). 
Patients must be able to read in Indonesian. 
They must prove their ability when 
researchers ask respondents to fill out the 
questionnaire's demographic data, and 
patients must be above 18 years old (adults). 
Patients must be willing to participate in the 
study and sign an informed consent form. 
The exclusion criteria were patients with 
acute liver disease (disease of the liver that 
lasts longer than six months), patients with 
chemotherapy (liver cancer), the latest 
chronic liver diseases, and liver 
transplantation.  Patients admitted to the 




The demographic of participants is 
shown in Table 1. The average age was 46.04 
years old; the youngest participant was 18 
years old, and the oldest was 88 years old. A 
majority of participants were in the 41-60-
year-old age group (n=48, 47.1 %). Males 
were 52.9% of the total population (n=54). 
82.4% (n=84) of participants were classified 
as having a low education level regarding 
education level. Most of the participants were 
self-employed, at 86.3% (n=88). Participants 
who were married constituted 83.3 % (n=85) 
of the total. The chronic liver disease duration 
since diagnosis for half of the participants 
(50%, n=51) was less than one year (more 
than six months). Regarding religion, most of 
the participants were Christian, accounting for 
62.7 % (n=64). Significantly, the most 
ethnicities among the participants were Batak, 
at 72.5 %. Overall, a slight majority of 
participants (54,9%) had monthly incomes 
less than 1,500 IDR. 
The results on the Self-Efficacy scale are 
shown in Table 4.2. Self-Efficacy was tested 
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using Chronic Disease Self-Efficacy Scales 
Indonesian Version. It found that most 
respondents had middle Self-Efficacy that 
contributes 58.9%, followed by high Self-
Efficacy (38.2%) and low Self-Efficacy with 
2.9%. 
 
Table 1. Descriptive Characteristics of 
Participant 
 
Variable N % 
Age 






































Duration Since Diagnosis 
<1 year 















































Table 2. Descriptive Statistics of Self 
Efficacy 















The total number of participants was 102 
outpatients and inpatients. The average age 
was 46.04 years old, with the youngest 
participant 18 years old and the oldest 88 
years old. At 47.1%, the highest number of 
participants was in the 41 – 60 age group. The 
20 – 40 age group accounted for 38.2% of 
participants, with 14.7% of participants over 
60 years old. The participants' average age in 
this study was similar to a study of 72 
cirrhosis patients conducted in Iran,10 who 
also had an average age of 47 years old. The 
study set out to evaluate the effectiveness of 
an educational intervention for patients with 
liver cirrhosis. That study used the Chronic 
Liver Disease Questionnaire and a knowledge 
questionnaire to assess patients' knowledge 
and quality of life.  The findings of 
participants' age from this study and another 
study because of patients over 40 years old 
were likely suffered from chronic liver 
disease than other age groups. 
A study was assessed to determine 
whether HRQL (health-related quality of life) 
in patients with chronic liver disease differs 
by type and severity of the liver disease. They 
also aimed to identify which clinical and 
physiological factors affect liver function. 
Like this study, chronic liver disease patients 
had an average age of 50, with 51% men11.  
 Participants in a study conducted in 
South Korea12 also had similar demographic 
characteristics to those of this study. The total 
number of chronic liver disease patients was 
139 drawn from the sixth Korean National 
Health and Nutrition Examination Survey 
(KNHNES VI). In that study, most patients 
(56.9%) were in the 45-64 age group, only 
slightly older than the most populous age 
group of 41-60 in this study; the average age 
of participants was also slightly older at 55.3 
years. Kim et al. likewise mentioned that most 
of the respondents were male (62.6%). It 
might be caused by alcohol-consuming by 
most of the males. Batak's male was popular 
with drinking "tuak", the traditional alcohol 
since they were young. A study by the 
research team at the University of California 
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in 2007 stated that the production of a protein 
that promotes inflammation appears to be 
linked to higher liver cancer in men than in 
women.  Regarding the level of education, at 
82.4%, the number of participants with low 
education in this study was somewhat higher 
than 72.2% in the Korean study. In the Korean 
study, participants who were married and 
living with their spouses accounted for 81.2 % 
of total participants. At 83.3%, the number of 
married respondents was slightly higher in 
this study. 
In this study, the duration of the chronic 
liver disease since diagnosis for half of the 
participants was less than one year (more than 
six months), followed by one year to 2 years 
at 32.4 %, with 17.6% of patients diagnosed 
than two years ago. The patients in this study 
were quite different from those in a study of 
hepatitis B surface antigen-positive patients,11 
in which the majority of patients (60%) had 
been diagnosed more than ten years ago. That 
study also used a cross-sectional design. The 
data in that study were collected from the 
patients using different tools, namely, the 
LDSI 2.0, Chronic Liver Disease 
Questionnaire, and EuroQol.Their sample's 
mean age was 43.3 years, and the majority of 
patients were men (77.6%). Nearly 90% of the 
patients in this Iranian sample were married, 
compared to 83.3% in this study, and more 
than half of them were employed (56.1%), 
whereas all the patients in this study were 
employed. Most of the Iranian patients lived 
in urban areas (97.1%). 
A study of chronic viral liver disease 
patients conducted in Serbia. They found that 
the mean age for patients with chronic viral 
liver disease was 39 years old, with 
participants ranging from age 16 to 66 years, 
and a high percentage of males (64.3%).  Most 
of the participants in the Serbian study were 
also married, constituting 61.7% of the total.7  
Self-efficacy is an individual's belief in 
their innate ability to achieve goals. Albert 
Bandura defines it as a personal judgment of 
"how well one can execute courses of action 
required to deal with prospective situations." 
People always struggle to control situations 
that influence their lives.3 Perceived self-
efficacy is defined as a person's beliefs about 
their capabilities to perform tasks at the 
desired level. Self-efficacy beliefs determine 
how people feel, think, motivate themselves, 
and behave.  
This study measured self-efficacy among 
chronic liver disease patients using the 
Chronic Disease Self-efficacy Scales created 
by Psychometric Data Stanford for its Chronic 
Disease Self-Management Study. This 
psychometric instrument was made available 
and free for public use by Lorig and 
colleagues' in 1996.13 Since this study was 
conducted in Indonesia, the researcher used 
the Indonesian version. To measure self-
efficacy, this study used the Chronic Disease 
Self-efficacy Scales, which consists of 39 
questions. The Indonesian version was 
validated in a study of chronic kidney disease 
patients in Indonesia recruited 39 
respondents.14 The questionnaire consists of 
ten indicators, namely, regular exercise (three 
items), getting information on the disease 
(one item), obtaining help from the 
community, family, friends (four items), 
communicating with physicians (three items), 
managing the disease in general (five items), 
doing chores (three items), doing 
social/recreational activities (two items), 
managing symptoms (five items), managing 
shortness of breath (one item), and 
controlling/managing depression (six items). 
This study's findings showed that a 
substantial majority of participants had 
moderate self-efficacy (n=60, 58.8%). In 
comparison, about 40% had high self-efficacy 
(n = 39, 38.2%), and a tiny minority had low 
self-efficacy (n=3, 2.9%). Self-efficacy may 
increase or decrease over time, depending on 
life events. The questionnaire could be used 
by nurses, social workers, and other health 
professionals to strengthen patients' self-
efficacy by engaging in activities it describes, 
such as encouraging or accompanying 
patients to ask doctors questions and 
informing doctors of it in advance. It is 
possible that most of the patients in this study 
had moderate self-efficacy because many 
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individuals with the chronic liver disease 
suffer chronic fatigue, abdominal pain and 
swelling, itchy skin, nausea or vomiting, loss 
of appetite, and other symptoms that affect 
self-efficacy.  
The findings of this study were similar to 
those of another chronic disease study among 
patients with COPD. They found that most of 
the participants had low self-efficacy. The 
study explained that symptoms—specifically, 
breathing difficulties while participating in 
many activities—were a major reason15. A 
study conducted in Israel rated the self-
efficacy among nonalcoholic fatty liver 
disease patients as medium-high. The same 
study pointed out that self-efficacy was lower 
among nonalcoholic fatty liver disease 
patients than patients with other liver 
diseases. Sagi et al. explained the role of self-
efficacy as a determinant of patients' success 
at maintaining lifestyle modifications. In 
general, most chronic disease patients have 
moderate to low self-efficacy. However, a 
study of chronic kidney disease patients 
conducted in Indonesia produced different 
results, finding high self-efficacy among 
almost two-thirds (66.67%) of those 
patients.13 However, previous studies about 
self-efficacy among patients with chronic 
liver disease are scarce, pointing to a need for 
more studies that test the self-efficacy, 
especially in chronic liver disease 
 
CONCLUSION 
Healthcare professionals should design 
supportive programs for older patients to 
strengthen their self-efficacy and educate 
them about the disease and where to go for 
treatment since chronic liver disease requires 
cooperation from both patients and healthcare 
providers. In addition, nurses should 
collaborate with other departments to arrange 
a private counseling room so that patients who 
need to talk privately with health providers 
can do so. A private space is needed to discuss 
life events that affect self-efficacy since other 
hospitals do not afford this. Nurses should 
also encourage patients to form support 
groups outside the hospital. Also, nurses or 
healthcare professionals should encourage the 
family to take care of the patients. 
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